- Home
- Publications
- Publication Search
- Publication Details
Title
Regulation of aldosterone secretion by Cav1.3
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-04-21
DOI
10.1038/srep24697
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DACH1, a Zona Glomerulosa Selective Gene in the Human Adrenal, Activates Transforming Growth Factor- Signaling and Suppresses Aldosterone Secretion
- (2015) J. Zhou et al. HYPERTENSION
- LGR5 Activates Noncanonical Wnt Signaling and Inhibits Aldosterone Production in the Human Adrenal
- (2015) Lalarukh Haris Shaikh et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas
- (2015) Silvia Monticone et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Evaluating State Dependence and Subtype Selectivity of Calcium Channel Modulators in Automated Electrophysiology Assays
- (2014) Yuri A. Kuryshev et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- Genetic Spectrum and Clinical Correlates of Somatic Mutations in Aldosterone-Producing Adenoma
- (2014) Fabio Luiz Fernandes-Rosa et al. HYPERTENSION
- Modest CaV1.342-selective inhibition by compound 8 is β-subunit dependent
- (2014) Hua Huang et al. Nature Communications
- Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators
- (2014) Nadine J. Ortner et al. Nature Communications
- Development of monoclonal antibodies against human CYP11B1 and CYP11B2
- (2013) Celso E. Gomez-Sanchez et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension
- (2013) Elena A B Azizan et al. NATURE GENETICS
- Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism
- (2013) Ute I Scholl et al. NATURE GENETICS
- Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies
- (2012) A. Hannemann et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson's disease
- (2012) Soosung Kang et al. Nature Communications
- A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism
- (2011) Hari K Parthasarathy et al. JOURNAL OF HYPERTENSION
- Aliskiren and the calcium channel blocker amlodipine combination as an initial treatment strategy for hypertension control (ACCELERATE): a randomised, parallel-group trial
- (2011) Morris J Brown et al. LANCET
- A comprehensive review of the clinical aspects of primary aldosteronism
- (2011) Gian Paolo Rossi Nature Reviews Endocrinology
- Structural and functional differences between L-type calcium channels: crucial issues for future selective targeting
- (2011) Annalisa Zuccotti et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Aldosterone Synthase Inhibition With LCI699
- (2010) Laurence Amar et al. HYPERTENSION
- Optimization of Cav1.2 screening with an automated planar patch clamp platform
- (2009) Bharathi Balasubramanian et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
- (2008) John W. Funder et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Expression and 1,4-Dihydropyridine-Binding Properties of Brain L-Type Calcium Channel Isoforms
- (2008) M. J. Sinnegger-Brauns et al. MOLECULAR PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started